Open AccessClinical N3 is an independent risk factor of recurrence for breast cancer patients achieving pathological complete response and near-pathological complete response after neoadjuvant chemotherapy
Author(s) -
Xiaoyan Qian,
Meng Xiu,
Qing Li,
Jiayu Wang,
Ying Fan,
Yang Luo,
Ruigang Cai,
Qiao Li,
Shanshan Chen,
Peng Yuan,
Fei Ma,
Binghe Xu,
Pin Zhang
Publication year - 2022
Publication title -
frontiers in oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.834
H-Index - 83
ISSN - 2234-943X
DOI - 10.3389/fonc.2022.1019925
Subject(s) - breast cancer , medicine , pathological , chemotherapy , oncology , neoadjuvant therapy , cancer , complete response , population , gastroenterology , environmental health
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom